Second-generation versus first-generation antipsychotic drugs for schizophrenia
Second-generation versus first-generation antipsychotic drugs for schizophrenia is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Second-generation versus first-generation antipsychotic drugs for schizophrenia
ID - 454628
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454628/all/Second_generation_versus_first_generation_antipsychotic_drugs_for_schizophrenia
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -